These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32861716)

  • 1. T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
    Pastori D; Carnevale R; Stanzione R; Nocella C; Cotugno M; Marchitti S; Bianchi F; Forte M; Valenti V; Biondi-Zoccai G; Schiavon S; Vecchio D; Versaci F; Frati G; Violi F; Volpe M; Pignatelli P; Rubattu S; Sciarretta S
    Int J Cardiol; 2021 Jan; 322():245-249. PubMed ID: 32861716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients.
    Rubattu S; De Giusti M; Farcomeni A; Abbolito S; Comito F; Cangianiello S; Greco ES; Dito E; Pagliaro B; Cotugno M; Stanzione R; Marchitti S; Bianchi F; Di Castro S; Battistoni A; Burocchi S; Caprinozzi M; Pierelli G; Sciarretta S; Volpe M
    J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):601-7. PubMed ID: 25252038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases.
    Rubattu S; Sciarretta S; Marchitti S; Bianchi F; Forte M; Volpe M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.
    Sciarretta S; Marchitti S; Bianchi F; Moyes A; Barbato E; Di Castro S; Stanzione R; Cotugno M; Castello L; Calvieri C; Eberini I; Sadoshima J; Hobbs AJ; Volpe M; Rubattu S
    Circ Res; 2013 May; 112(10):1355-64. PubMed ID: 23529183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
    Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
    Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide T2238C gene polymorphism and the risk of cardiovascular diseases: A meta‑analysis.
    Wang J; Yang Y; Zheng M; Zhang L; Wulasihan M
    Biomed Rep; 2024 Mar; 20(3):41. PubMed ID: 38357235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
    Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.
    Carnevale R; Pignatelli P; Frati G; Nocella C; Stanzione R; Pastori D; Marchitti S; Valenti V; Santulli M; Barbato E; Strisciuglio T; Schirone L; Vecchione C; Violi F; Volpe M; Rubattu S; Sciarretta S
    Sci Rep; 2017 Jun; 7(1):3797. PubMed ID: 28630469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO-AF study.
    Pastori D; Menichelli D; Bucci T; Violi F; Pignatelli P;
    Int J Cancer; 2020 Dec; 147(12):3424-3430. PubMed ID: 32588421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
    Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
    Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro.
    Stanzione R; Sciarretta S; Marchitti S; Bianchi F; Di Castro S; Scarpino S; Cotugno M; Frati G; Volpe M; Rubattu S
    Cell Death Dis; 2015 Dec; 6(12):e2033. PubMed ID: 26720342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events.
    Carnevale R; Nocella C; Pignatelli P; Bartimoccia S; Stefanini L; Basili S; Novo M; D'Amico A; Cammisotto V; Pastori D; Violi F
    Atherosclerosis; 2018 Jul; 274():29-34. PubMed ID: 29747088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
    Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
    Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study.
    Menichelli D; Sciacqua A; Cangemi R; Andreozzi P; Del Sole F; Violi F; Pignatelli P; Pastori D;
    Int J Clin Pract; 2021 Mar; 75(3):e13771. PubMed ID: 33078565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation.
    Tuinenburg AE; Brundel BJ; Van Gelder IC; Henning RH; Van Den Berg MP; Driessen C; Grandjean JG; Van Gilst WH; Crijns HJ
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):827-35. PubMed ID: 10376920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
    J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
    Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in
    Cheng C; Liu H; Tan C; Tong D; Zhao Y; Liu X; Si W; Wang L; Liang L; Li J; Wang C; Chen Q; Du Y; Wang QK; Ren X
    FASEB J; 2019 Aug; 33(8):8878-8891. PubMed ID: 31034774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro.
    Scarpino S; Marchitti S; Stanzione R; Evangelista A; Di Castro S; Savoia C; Quarta G; Sciarretta S; Ruco L; Volpe M; Rubattu S
    J Hypertens; 2009 Sep; 27(9):1804-13. PubMed ID: 19702001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.